Navigation Links
Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance
Date:12/11/2008

eeting bode well for the future of our company and the patients we serve."

"The pharmaceutical industry, however, continues to face major challenges, and we must act quickly and decisively to address them," noted Lechleiter. "We must respond to the demand for greater value among payers, providers and patients. We must also prepare for the wave of patent expirations that will come in the early part of the next decade. At Lilly, we recognize those challenges, and also recognize the tremendous opportunities that can be created by a company with a clear vision and a commitment to change. We are fundamentally transforming our business, and are doing so from a position of strength. Our strategy is to create value for our stakeholders by accelerating the flow of innovative new medicines that provide improved outcomes for individual patients."

Pipeline Progress - Expanding Biotech, Reducing Costs and Increasing Productivity

Steven M. Paul, M.D., executive vice president, science and technology and president of Lilly Research Laboratories, explained how Lilly's strategy for research and development is designed to respond to the challenges of pharmaceutical R&D. "Lilly's goal is to substantially improve R&D productivity and reduce late-stage attrition, thereby lowering the cost to bring a new molecular entity (NME) to market, from $1.2 billion in 2007 to $800 million by 2010. Our most recent estimate of $1.0 billion shows that we are making significant progress toward achieving this goal through our R&D transformation."

Dr. Paul then detailed several key U.S. and international examples of FIPNet transformation and their positive impact on R&D productivity. These examples include the sale of Lilly's Greenfield Laboratories site to Covance, the expansion of Chorus, Lilly's virtual drug development organization, the creation of a joint venture in India with Jubilant Organosys, and other
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
2. Lilly Declares Fourth-Quarter Dividend
3. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
4. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
5. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
6. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
7. Lilly Announces Termination of AIR Insulin Program
8. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
9. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
10. Lilly Reports Solid First-Quarter Results
11. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Filtration and Separations Society will hold its 23rd Annual Technical Conference ... in San Antonio, Texas. To further impact the separation society and ... proud to announce that the 2010 AFS Annual Technical Conference will ... , ... Minneapolis, MN (PRWEB) December 16, 2009 -- The ...
(Date:12/15/2009)... -- Repligen Corporation (Nasdaq: RGEN ) today ... research funding to support the ongoing development of ... Dystrophy Association (MDA). This grant will support ... GMP manufacture of a drug candidate for human ... only provides important funding for Repligen,s research but ...
(Date:12/15/2009)... Medical, Inc. (OTC Bulletin Board : AEMD) announced ... Comper have joined the Science Advisory ... Schorey and Dr. Comper are leading researchers in ... of Aethlon Medical, was recently formed to leverage ... being advanced as an adjunct therapy for Hepatitis-C ...
(Date:12/15/2009)... (NYSE: MOS ) plans to issue its ... tables on Tuesday, January 5, 2010, after the close ... Results will be available on Mosaic,s website at mosaicco.com/investors. ... call with presentation slides on Wednesday, January 6, 2010, ... at 11:00 a.m. Eastern Standard Time (10:00 a.m. Central ...
Breaking Biology Technology:American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 2Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 4Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 5Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2
... MILWAUKEE, WI - Representatives of the Medical College of ... were featured on a Milwaukee business television show, Avante's ... September 27, on WISN. , ,Dr. Jeffrey Smith, clinical ... Wisconsin Medical School was joined by Mike Klein, ...
... from his position as director of the nonpartisan ... the reasons for his ouster. , ,And while Senate ... of an audit of the bureaus performance as the ... John Gard (R-Peshtigo) said the move was simple politics. ...
... Though results for third-quarter publicly traded biotech stocks continue ... be slowing down (or else the rest of the market ... to lead with year-to-date sizzling growth of 42 percent versus ... Jones Industrials respectable growth of 12 percent. The Amex Biotech ...
Other Biology Technology:The Information Age of Healthcare - Leaders featured on local new economy show 2The Information Age of Healthcare - Leaders featured on local new economy show 3Wahl Mute on Firing from Legislative IT Bureau -- but politics could be to blame 2Midwest Public-Sector Biotech Continues to Sizzle 2
(Date:12/16/2009)... -- IgeaCare Solutions Inc. is pleased to announce ... communications company previously operating as IgeaCare Systems Inc. ... forward under new leadership and funding. ,, IgeaCare ... the position of Chief Executive Officer. Under his ... a superior servicing and support model; fast and ...
(Date:12/15/2009)... 15 The 2009 Frost & ... is presented to Sagem Securite (Safran Group) ... The award recognises the company,s expertise in ... in offering novel, value-added products to end ... ) ,, "Sagem Securite has been involved ...
(Date:12/15/2009)... Inc. GenWay Clinical Laboratory, San Diego, California, has ... American Pathologists (CAP), based on results of a ... director was advised of this national recognition and ... provided." GenWay Biotech Inc. GenWay Clinical Laboratory is ... The CAP Laboratory Accreditation Program, begun in the ...
Breaking Biology News(10 mins):IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 4MediciGlobal Achieves Record Number of Awards 51914 1MediciGlobal Achieves Record Number of Awards 51914 2Apieron Inc Files Infringement Complaint Against Aerocrine AB Aerocrine AG and Mr Magnus Pelles 51909 1St Alexius Medical Center Named to Americas Best Hospitals Rankings 51905 1St Alexius Medical Center Named to Americas Best Hospitals Rankings 51905 2
... and then moving into mice and humans, researchers at VIB and ... cancer in all three organisms. Reciprocally, switching off the gene ... cancer. The authors show there is a good chance that the ... their findings in two papers in the leading online open access ...
... method for identifying levels of exposure to environmental arsenic ... naturally in the environment and people can be exposed ... water, food, dust or soil. The risk of exposure ... the natural geology and historic mining activities have led ...
... 22, 2009--Researchers at the Dana-Farber Cancer Institute (Dana-Farber), ... Centers for Disease Control and Prevention (CDC) have ... that neutralize an unprecedented range of influenza A ... pandemic influenza viruses, and some seasonal influenza viruses. ...
Other Biology News:Suppressing cancer with a master control gene 2Arsenic and old toenails 2Scientists identify human monoclonal antibodies effective against bird and seasonal flu viruses 2Scientists identify human monoclonal antibodies effective against bird and seasonal flu viruses 3
... The Fujifilm Life Science LAS-3000 ... technology with a simplified user interface, ... a wide range of modularities. The ... applications, and the perfect standard system ...
... Life Science LAS-3000mini is a compact ... chemiluminescence applications, and the perfect standard ... 's LAS-3000 provides significantly improved system ... Glowell calibration standards validate that Fujis ...
... assays. The TUNEL-based assay kit provides complete ... for convenient detection of DNA fragmentation in ... offers an one-step labeling of apoptotic cells. ... hallmark of apoptosis in mammalian cells. MBLs ...
SDS-OutT Precipitation Reagent...
Biology Products: